Development - Quality - CMC - Authorisation - Market Access
Webcode 26032470
23 - 24/03/2026
23 - 24/03/2026
Day 1: 09:00 am - 05:00 pm CET - Online training
Day 2: 09:00 am - 05:30 pm CET - Online training
You may dial in 30 minutes before the session starts
online
online
Event - 1,990€ plus tax
The participation fee includes documentation for download, a certificate, access to the Learning Space and technical support including PreMeeting.
Event - 1,990€ plus tax
The participation fee includes documentation for download, a certificate, access to the Learning Space and technical support including PreMeeting.
Dr. Birgit Wessels
Konferenzmanagerin Healthcare
+49 6221 500-652
b.wessels@forum-institut.de
The online training with details on development, quality, CMC, approval and market access (including an update on the upcoming EU HTA) for advanced therapy medicinal products. Qualifiy now!
During this seminar, you will learn to master the challenges from development to approval to market access of an ATMP. After the seminar, you will know which GMP regulations must be included for ATMPs as part of product development. You will be familiar with the requirements for clinical and non-clinical development too. In addition, you have been brought up to date with regard to the regulatory requirements for marketing authorization (national, EU). You know the individual steps in the central approval procedure and the requirements for hospital exemption. Last but not least, you have acquired the know-how to set the right course for benefit assessment and market access (including an update on the EU HTA, first experiences with ATMPs).
After participating in this online seminar you will be equipped with a tool box as well as practical tipps and hints to master
